Preview Mode Links will not work in preview mode

Keeping Current CME

Mar 27, 2023

Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
Credit available for this activity expires: 3/27/2024
Earn Credit / Learning Objectives & Disclosures: